• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O-RADS MRI 评分:附件包块特征化的基本首要工具。

O-RADS MRI SCORE: An Essential First-Step Tool for the Characterization of Adnexal Masses.

机构信息

Assistante Publique des Hôpitaux de Paris, Department of Radiology Imaging and Interventional Radiology (IRIS), Tenon Hospital, APHP, Sorbonne University, 75005, Paris, Paris, France.

Saint-Antoine Research Cancer Center, Sorbonne University, Paris, France.

出版信息

J Magn Reson Imaging. 2024 Mar;59(3):720-736. doi: 10.1002/jmri.28947. Epub 2023 Aug 7.

DOI:10.1002/jmri.28947
PMID:37550825
Abstract

The ovarian-adnexal reporting and data system on magnetic resonance imaging (O-RADS MRI) score is now a well-established tool to characterize pelvic gynecological masses based on their likelihood of malignancy. The main added value of O-RADS MRI over O-RADS US is to correctly reclassify lesions that were considered suspicious on US as benign on MRI. The crucial issue when characterizing an adnexal mass is to determine the presence/absence of solid tissue and thus need to perform gadolinium injection. O-RADS MR score was built on a multivariate analysis and must be applied as a step-by-step analysis: 1) Is the mass an adnexal mass? 2) Is there an associated peritoneal carcinomatosis? 3) Is there any significant amount of fatty content? 4) Is there any wall enhancement? 5) Is there any internal enhancement? 6) When an internal enhancement is detected, does the internal enhancement correspond to solid tissue or not? 7) Is the solid tissue malignant? With its high value to distinguish benign from malignant adnexal masses and its high reproducibility, the O-RADS MRI score could be a valuable tool for timely referral of a patient to an expert center for the treatment of ovarian cancers. Finally, to make a precise diagnosis allowing optimal personalized treatment, the radiologist in gynecological imaging will combine the O-RADS MRI score with many other clinical, biological, and other MR criteria to suggest a pathological hypothesis. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY STAGE: 3.

摘要

卵巢-附件磁共振成像报告和数据系统 (O-RADS MRI) 评分现已成为一种成熟的工具,可根据盆腔妇科肿块的恶性可能性对其进行特征描述。与 O-RADS US 相比,O-RADS MRI 的主要附加价值是正确地重新分类在 US 上被认为可疑的病变为 MRI 上良性的病变。描述附件肿块的关键问题是确定是否存在实性组织,因此需要进行钆造影剂注射。O-RADS MRI 评分是基于多变量分析构建的,必须作为逐步分析来应用:1)肿块是否为附件肿块?2)是否存在腹膜癌转移?3)是否有大量脂肪含量?4)是否有壁强化?5)是否有内部强化?6)当检测到内部强化时,内部强化是否对应于实性组织?7)实性组织是否为恶性?由于其对区分良性和恶性附件肿块具有很高的价值和很高的可重复性,O-RADS MRI 评分可能是及时将患者转诊至专家中心治疗卵巢癌的有价值的工具。最后,为了做出准确的诊断,从而实现最佳的个体化治疗,妇科影像学放射科医生将结合 O-RADS MRI 评分以及许多其他临床、生物学和其他磁共振标准,提出病理假说。证据水平:5 技术功效分期:3。

相似文献

1
O-RADS MRI SCORE: An Essential First-Step Tool for the Characterization of Adnexal Masses.O-RADS MRI 评分:附件包块特征化的基本首要工具。
J Magn Reson Imaging. 2024 Mar;59(3):720-736. doi: 10.1002/jmri.28947. Epub 2023 Aug 7.
2
Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.扩散加权成像定量分析在卵巢-附件报告和数据系统磁共振成像中的附加价值。
J Magn Reson Imaging. 2022 Jul;56(1):158-170. doi: 10.1002/jmri.28003. Epub 2021 Nov 19.
3
How to improve O-RADS MRI score for rating adnexal masses with cystic component?如何提高 O-RADS MRI 评分以评估具有囊性成分的附件肿块?
Eur Radiol. 2022 Sep;32(9):5943-5953. doi: 10.1007/s00330-022-08644-3. Epub 2022 Mar 24.
4
Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?提高 MRI 检查中附件包块性质不明的风险分层:O-RADS MRI 4 级病变中哪些影像学特征有助于预测恶性肿瘤?
Eur J Radiol. 2023 Nov;168:111122. doi: 10.1016/j.ejrad.2023.111122. Epub 2023 Sep 28.
5
O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates.O-RADS MRI:诊断性能和分类恶性率的系统评价和荟萃分析。
Radiology. 2023 Apr;307(1):e220795. doi: 10.1148/radiol.220795. Epub 2022 Nov 22.
6
O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort.O-RADS MRI 评分:前瞻性多中心欧洲队列中分类错误病例的分析。
Eur Radiol. 2021 Dec;31(12):9588-9599. doi: 10.1007/s00330-021-08054-x. Epub 2021 May 26.
7
Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.美国放射学院卵巢-附件报告和数据系统超声(O-RADS US)的验证:对 1054 个附件肿块的分析。
Gynecol Oncol. 2021 Jul;162(1):107-112. doi: 10.1016/j.ygyno.2021.04.031. Epub 2021 May 7.
8
Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.卵巢-附件报告数据系统磁共振成像(O-RADS MRI)评分用于超声不确定附件肿块的风险分层。
JAMA Netw Open. 2020 Jan 3;3(1):e1919896. doi: 10.1001/jamanetworkopen.2019.19896.
9
Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.O-RADS 超声和 O-RADS MRI 用于卵巢和附件病变风险评估的系统评价和荟萃分析。
AJR Am J Roentgenol. 2023 Jul;221(1):21-33. doi: 10.2214/AJR.22.28396. Epub 2023 Feb 1.
10
Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.基于增强非动态对比增强磁共振成像(MRI)的O-RADS MRI风险分层系统在附件包块评估中的准确性和可重复性
Eur J Radiol. 2023 Feb;159:110670. doi: 10.1016/j.ejrad.2022.110670. Epub 2022 Dec 24.

引用本文的文献

1
Unenhanced magnetic resonance imaging in the risk stratification of indeterminate adnexal masses: a viable solution in the face of clinical limitations?未增强磁共振成像在附件包块性质不明的风险分层中的应用:面对临床局限性时的可行解决方案?
Radiol Bras. 2025 Aug 1;58:e1. doi: 10.1590/0100-3984.2025.58.e1-en. eCollection 2025 Jan-Dec.
2
The added value of apparent diffusion coefficient assessments in O-RADS MRI evaluation for characterizing ovarian masses with solid components.在O-RADS MRI评估中,表观扩散系数评估对于具有实性成分的卵巢肿块特征描述的附加价值。
Abdom Radiol (NY). 2025 Aug 29. doi: 10.1007/s00261-025-05138-w.
3
CT and MRI in Advanced Ovarian Cancer: Advances in Imaging Techniques.
晚期卵巢癌的CT与MRI:成像技术进展
Korean J Radiol. 2025 Sep;26(9):841-854. doi: 10.3348/kjr.2025.0357.
4
Navigating Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging (O-RADS MRI): A Review of Its Evolution, Current Advances, and Persistent Challenges in Ovarian Imaging.解读卵巢附件报告和数据系统磁共振成像(O-RADS MRI):卵巢成像中其演变、当前进展及持续挑战的综述
Cureus. 2025 Jun 25;17(6):e86717. doi: 10.7759/cureus.86717. eCollection 2025 Jun.
5
Bone Reporting and Data System on MRI (Bone-RADS-MRI): a validation study by four readers on 275 cases from three local and two public databases.MRI骨报告与数据系统(骨影像报告和数据系统 - MRI):由四位阅片者对来自三个本地数据库和两个公共数据库的275例病例进行的验证研究
Insights Imaging. 2025 Jul 17;16(1):155. doi: 10.1186/s13244-025-02040-3.
6
Genital Tuberculosis and Serous Cystadenoma in a 58-Year-Old Female With Rheumatoid Arthritis and Sjögren's Syndrome: A Case Report.一名患有类风湿性关节炎和干燥综合征的58岁女性的生殖器结核和浆液性囊腺瘤:病例报告
Case Rep Rheumatol. 2025 May 6;2025:9372058. doi: 10.1155/crrh/9372058. eCollection 2025.
7
Efficacy of a combination of O-RADS, CEUS, and CA125, in identification of ovary-adnexal malignant lesions.O-RADS、超声造影(CEUS)和CA125联合应用在识别卵巢附件恶性病变中的效能
Am J Cancer Res. 2025 Feb 15;15(2):631-642. doi: 10.62347/JHJJ1149. eCollection 2025.
8
Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group.卵巢癌分期与随访:欧洲泌尿生殖放射学会女性盆腔影像工作组的更新指南
Eur Radiol. 2025 Jan 11. doi: 10.1007/s00330-024-11300-7.
9
Primarian fallopian tube carcinoma: Clinical and radiological keys for diagnosis.原发性输卵管癌:诊断的临床和影像学要点
Radiol Case Rep. 2024 Jul 29;19(10):4380-4384. doi: 10.1016/j.radcr.2024.06.052. eCollection 2024 Oct.
10
ESR Essentials: characterisation and staging of adnexal masses with MRI and CT-practice recommendations by ESUR.ESR 精华:MRI 和 CT 对附件包块的特征及分期——ESUR 实践推荐
Eur Radiol. 2024 Dec;34(12):7673-7689. doi: 10.1007/s00330-024-10817-1. Epub 2024 Jun 7.